Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

The firm presented data at AACR that showed the test had high accuracy when distinguishing ovarian cancer at early stages.

The test, which was granted Breakthrough Device Designation by the FDA, is the first FDA cleared blood-based IVD test in the U.S. to aid to identify patients with amyloid pathology associated ... the ...

To effectively battle cancer, scientists must study the battlefield. Now, in a recent study published in Nature ...

Watch Lorraine Kelly reveals her ovaries were removed after ovarian cyst: Lorraine Kelly returned to her show this morning ...

Facility-level disparities in adopting minimally invasive interval debulking surgery for ovarian cancer highlight urgent ...

The U.S. Federal Drug Administration (FDA) has granted Incyclix Bio Fast Track designation for INX-315 to treat ...

In line with previous clinical trial findings, real-world data show that bevacizumab improves outcomes in patients with ...

Diagnosed with ovarian cancer in 2021, Ivy's life took an unexpected ... it's a window into the transformative impact of art therapy. In the battle against cancer, beyond pathology reports and CT ...

Maintenance with niraparib and bevacizumab can be effective in patients with platinum-sensitive, recurrent ovarian cancer previously treated with a PARP inhibitor.

The Breast Cancer Now Nina Barough Pathology Core Facility provides diagnostic and research-based histopathology to both the Breast Cancer Now Research Centre and research teams within The Institute ...

On World Ovarian Cancer Day, doctors share key symptoms, risk factors, and lifestyle tips to help women lower their risk of this often undetected disease. Ovarian cancer can be benign or malignant ...